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Background
Immunization strategies that elicit antibodies capable of
neutralizing diverse strains of the virus will likely be an
important part of a successful vaccine against HIV. The
envelope trimer is the only neutralizing target on the
virus, and strategies to promote durable, high avidity anti-
body responses against the native intact trimer structure
are lacking. We recently developed chemically-crosslinked
lipid nanocapsules as carriers of molecular adjuvants and
encapsulated or surface-displayed antigens, which promote
follicular helper T-cell responses and elicited high-avidity,
durable antibody responses to a candidate malaria antigen
(Moon et al. Nat. Mater. 10 243 (2011); Moon et al. PNAS
109 1080 (2012)).
Methods
To apply this system to the delivery of HIV antigens, we
developed a strategy to anchor recombinant envelope tri-
mers to the surfaces of these particles under conditions
preserving the antigenic integrity of the trimers, allowing
multivalent display of these immunogens for immuniza-
tion. To anchor trimers in their native orientation, gp140
trimers with terminal his-tags were anchored to the sur-
face of lipid nanocapsules via Ni-NTA-functionalized
lipids.
Results
Owing to their significant size (409 kDa) and heavy glyco-
sylation, we found that liquid-ordered and/or gel-phase
lipid compositions were required to stably anchor trimers
to particle membranes. Trimer-loaded nanocapsules carry-
ing monophosphoryl lipid A elicited durable antibody
responses with titers comparable to a Complete Freund’s
Adjuvant (CFA)-like emulsion in mice, without the toxic
inflammation associated with the latter adjuvant. Further,
nanocapsules elicited strong helper T-cell responses asso-
ciated with a steadily increasing avidity of trimer-binding
antibody over 90 days, which was not replicated by other
adjuvants.
Conclusion
These results suggest that nanoparticles displaying HIV
trimers in an oriented, multivalent presentation can pro-
mote key aspects of the humoral response against Env
immunogens.
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